Burning Rock Biotech Limited announced the resignation of Dr. Shaokun (Shannon) Chuai as a director from the board of directors of the Company and as the Companyâs Chief Scientific Officer, effective June 30, 2023. Dr. Shaokun (Shannon) Chuai will continue to serve as a senior advisor to the Company. Dr. Zhihong (Joe) Zhang, the Companyâs Chief Technology Officer since March 2016, has been appointed as a new director of the Board, effective June 30, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.15 USD | -5.30% | -5.30% | -23.12% |
1st Jan change | Capi. | |
---|---|---|
-23.12% | 73.35M | |
-24.16% | 7.76B | |
+68.65% | 4.33B | |
+2.72% | 2.63B | |
-2.98% | 2.64B | |
-46.17% | 2.16B | |
-15.27% | 1.75B | |
-22.12% | 1.46B | |
+13.62% | 1.17B | |
-43.81% | 1.14B |
- Stock Market
- Equities
- BNR Stock
- News Burning Rock Biotech Limited
- Burning Rock Biotech Limited Announces Management Changes, Effective June 30, 2023